BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 15491807)

  • 1. Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
    Agnihotri SA; Mallikarjuna NN; Aminabhavi TM
    J Control Release; 2004 Nov; 100(1):5-28. PubMed ID: 15491807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmucosal macromolecular drug delivery.
    Prego C; García M; Torres D; Alonso MJ
    J Control Release; 2005 Jan; 101(1-3):151-62. PubMed ID: 15588901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
    Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
    J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of low molecular drugs using chitosan and its derivatives.
    Park JH; Saravanakumar G; Kim K; Kwon IC
    Adv Drug Deliv Rev; 2010 Jan; 62(1):28-41. PubMed ID: 19874862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan nanoparticles for drug delivery to the eye.
    Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
    Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
    Prabaharan M
    J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.
    Borges O; Cordeiro-da-Silva A; Romeijn SG; Amidi M; de Sousa A; Borchard G; Junginger HE
    J Control Release; 2006 Sep; 114(3):348-58. PubMed ID: 16905219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-based delivery systems for protein therapeutics and antigens.
    Amidi M; Mastrobattista E; Jiskoot W; Hennink WE
    Adv Drug Deliv Rev; 2010 Jan; 62(1):59-82. PubMed ID: 19925837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
    Wu Y; Yang W; Wang C; Hu J; Fu S
    Int J Pharm; 2005 May; 295(1-2):235-45. PubMed ID: 15848008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl histidine-conjugated glycol chitosan self-assembled nanoparticles for intracytoplasmic delivery of drugs: endocytosis, exocytosis and drug release.
    Park JS; Han TH; Lee KY; Han SS; Hwang JJ; Moon DH; Kim SY; Cho YW
    J Control Release; 2006 Sep; 115(1):37-45. PubMed ID: 16935380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of chitosan and its derivatives in regenerative medicine.
    Shi C; Zhu Y; Ran X; Wang M; Su Y; Cheng T
    J Surg Res; 2006 Jun; 133(2):185-92. PubMed ID: 16458923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-mediated orally delivered nucleic acids: a gutful of gene therapy.
    Dass CR; Choong PF
    J Drug Target; 2008 May; 16(4):257-61. PubMed ID: 18446603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrogel nanoparticles in drug delivery.
    Hamidi M; Azadi A; Rafiei P
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1638-49. PubMed ID: 18840488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.
    Aktaş Y; Yemisci M; Andrieux K; Gürsoy RN; Alonso MJ; Fernandez-Megia E; Novoa-Carballal R; Quiñoá E; Riguera R; Sargon MF; Celik HH; Demir AS; Hincal AA; Dalkara T; Capan Y; Couvreur P
    Bioconjug Chem; 2005; 16(6):1503-11. PubMed ID: 16287248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
    de la Fuente M; Raviña M; Paolicelli P; Sanchez A; Seijo B; Alonso MJ
    Adv Drug Deliv Rev; 2010 Jan; 62(1):100-17. PubMed ID: 19958805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems.
    Rao GC; Kumar MS; Mathivanan N; Rao ME
    Pharmazie; 2004 Jan; 59(1):5-9. PubMed ID: 14964413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles as drug delivery systems.
    Manjunath K; Reddy JS; Venkateswarlu V
    Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.